TRACON Pharmaceuticals Inc (NASDAQ:TCON) currently has a daily average trading volume of 3.23M but it saw 8588313 shares traded in last market. With a market cap of 11.93M USD, the company’s current market price of $0.26 came rising about 19.50 while comparing to the previous closing price of $0.22. In past 52 weeks, the stock remained buoying in the range of price level as high as $2.14 and as low as $0.13.
Taking a look at 20-day trading activity of TRACON Pharmaceuticals Inc (TCON) gives us an average price of $0.3829, while its current price level is -87.74% below from 52-week high level whereas it is 109.00% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.2673 while that of 200 days or SMA-200 reads an average of $0.2361. A closer look into the stock’s movement over the week reveals that its volatility is standing at 34.20% during that period while stretching the period over a month that decreases to 31.14%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 43.51 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the BTIG Research which upgraded the stock as “Buy” in its note to investors issued on April 16, 2021, recommending a price target of $14 for it. H.C. Wainwright issued its recommendations for the stock as it reiterated the price target for the stock in the range of between $15 and $18.
Over the week, TCON’s stock price is moving -36.04% down while it is 39.89% when we observe its performance for the past one month. Year-to-date it is 49.80% up and over the past year, the stock is showing a downside performance of -86.51%.
The latest quarterly earnings report issued by the company was for quarter ended 12/30/2023, when its quarterly earnings per share (EPS) of $0.01 beat the consensus estimate of -$0.08 for the same. For TCON, analysts are forecasting an EPS-growth rate of -109.10% for current year and estimate for EPS growth in next year is 69.60%.
Currently, TRACON Pharmaceuticals Inc’s total number of outstanding shares is 44.27M with 2.59% of that held by the insiders while 11.87% of its common stock has been owned by the institutions. Stock’s beta reads 1.09. Stock has a price to sale or P/S ratio amounts to 0.99. Its return on asset (ROA) is -24.26% on average.
